"Disease Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)
| Descriptor ID |
D019468
|
| MeSH Number(s) |
N04.590.607
|
| Concept/Terms |
Disease Management- Disease Management
- Disease Managements
- Management, Disease
- Managements, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Management".
Below are MeSH descriptors whose meaning is more specific than "Disease Management".
This graph shows the total number of publications written about "Disease Management" by people in this website by year, and whether "Disease Management" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 4 | 5 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 2 | 7 | 9 |
| 2012 | 3 | 4 | 7 |
| 2013 | 2 | 6 | 8 |
| 2014 | 4 | 6 | 10 |
| 2015 | 9 | 14 | 23 |
| 2016 | 5 | 16 | 21 |
| 2017 | 12 | 16 | 28 |
| 2018 | 8 | 16 | 24 |
| 2019 | 6 | 18 | 24 |
| 2020 | 6 | 27 | 33 |
| 2021 | 2 | 13 | 15 |
| 2022 | 1 | 1 | 2 |
| 2023 | 2 | 1 | 3 |
| 2024 | 1 | 8 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Management" by people in Profiles.
-
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw. 2024 Nov; 22(9):582-592.
-
Secondary Mitral Regurgitation: Updated Review with Focus on Percutaneous Interventional Management. J Card Fail. 2024 Oct; 30(10):1302-1318.
-
Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC Heart Fail. 2024 Aug; 12(8):1328-1342.
-
Point/Counterpoint #2: Current Clinical Considerations With Nonoperative Management of Rectal Cancer. Cancer J. 2024 Jul-Aug 01; 30(4):256-263.
-
Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
-
Toward More Personalized Management of Device-Detected Atrial Fibrillation. JAMA Neurol. 2024 Jun 01; 81(6):573-574.
-
Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e432218.
-
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024. J Natl Compr Canc Netw. 2024 06; 22(2 D).
-
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome. Curr Treat Options Oncol. 2024 Jun; 25(6):752-768.
-
Common Instances of Low-value Care in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2024 May; 22(5):923-932.